Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 837 JPY -0.54% Market Closed
Market Cap: 45.7B JPY

Wall Street
Price Targets

Price Targets Summary
Fuji Pharma Co Ltd

Wall Street analysts forecast Fuji Pharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Fuji Pharma Co Ltd is 2 193 JPY with a low forecast of 2 020 JPY and a high forecast of 2 415 JPY.

Lowest
Price Target
2 020 JPY
10% Upside
Average
Price Target
2 193 JPY
19% Upside
Highest
Price Target
2 415 JPY
31% Upside
Fuji Pharma Co Ltd Competitors:
Price Targets
4887
Sawai Group Holdings Co Ltd
4% Upside
SNT
Syntara Ltd
325% Upside
AQST
Aquestive Therapeutics Inc
80% Upside
TLRY
Tilray Brands Inc
27% Upside
3692
Hansoh Pharmaceutical Group Company Ltd
16% Upside

Revenue
Forecast

Revenue Estimate
Fuji Pharma Co Ltd

For the last 13 years the compound annual growth rate for Fuji Pharma Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Fuji Pharma Co Ltd

Operating Income forecast
is not available for
Fuji Pharma Co Ltd

Net Income
Forecast

Net Income Estimate
Fuji Pharma Co Ltd

For the last 13 years the compound annual growth rate for Fuji Pharma Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 25%.

6%
Past Growth
25%
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Fuji Pharma Co Ltd's stock price target?
Price Target
2 193 JPY

According to Wall Street analysts, the average 1-year price target for Fuji Pharma Co Ltd is 2 193 JPY with a low forecast of 2 020 JPY and a high forecast of 2 415 JPY.

What is Fuji Pharma Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Fuji Pharma Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 12%.

What is Fuji Pharma Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 13 years the compound annual growth rate for Fuji Pharma Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 25%.

Back to Top